Innoviva, Inc. Share Price Today: Live Updates & Key Insights
Innoviva, Inc. share price today is $21.7, up -1.77%. The stock opened at $21.95 against the previous close of $22.09, with an intraday high of $22.07 and low of $21.64.
Innoviva, Inc. Share Price Chart
Innoviva, Inc.
Innoviva, Inc. Share Price Performance
Innoviva, Inc. Institutional Holdings
Innoviva, Inc. Market Status
Innoviva, Inc. Fundamentals
Market Cap 1659.87 M
PB Ratio 1.3711
PE Ratio 13.3735
Enterprise Value 1310.49 M
Total Assets 1635.17 M
Volume 2707203
Innoviva, Inc. Company Financials
About Innoviva, Inc. & investment objective
Company Information Innoviva, Inc. operates as a biopharmaceutical company in the United States and internationally. Its royalty portfolio includes RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol, and an inhaled corticosteroid, and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a long-acting muscarinic antagonist, umeclidinium bromide, and ABA, VI. The company also markets GIAPREZA for increasing blood pressure in adults with septic or other distributive shock; XACDURO, a co-packaged for intravenous use for the treatment of hospital-acquired and ventilator-associated bacterial pneumonia caused by Acinetobacter; XERAVA for the treatment of complicated intra-abdominal infections in adults; ZEVTERA an advanced-generation cephalosporin antibiotic for the treatment of staphylococcus aureus bacteremia, as well as with right-sided endocarditis, acute bacterial skin and skin structure infections, and community-acquired bacterial pneumonia; NUZOLVENCE for the treatment of uncomplicated urogenital gonorrhea in adults and adolescents. In addition, the company develops bacteriophages with potential use in a range of infectious and other serious diseases. It has a strategic partnership with Sarissa Capital Management LP; and LABA Collaboration Agreement with Glaxo Group Limited to develop and commercialize once-daily products for the treatment of chronic obstructive pulmonary disease and asthma. The company was formerly known as Theravance, Inc. and changed its name to Innoviva, Inc. in January 2016. Innoviva, Inc. was incorporated in 1996 and is headquartered in Burlingame, California.
Organisation Biotechnology
Employees 159
Industry Biotechnology
CEO Mr. Pavel Raifeld C.F.A.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
Innoviva, Inc. FAQs
What is the share price of Innoviva, Inc. today?
The current share price of Innoviva, Inc. is $21.7.
Can I buy Innoviva, Inc. shares in India?
Yes, Indian investors can buy Innoviva, Inc. shares by opening an international trading and demat account with Motilal Oswal.
How to buy Innoviva, Inc. shares in India?
You can easily invest in Innoviva, Inc. shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy Innoviva, Inc. shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of Innoviva, Inc..
Can I buy fractional shares of Innoviva, Inc.?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of Innoviva, Inc.?
Innoviva, Inc. has a market cap of $1659.87 M.
In which sector does Innoviva, Inc. belong?
Innoviva, Inc. operates in the Biotechnology sector.
What documents are required to invest in Innoviva, Inc. stocks?
To invest, you typically need:
What is the PE and PB ratio of Innoviva, Inc.?
The PE ratio of Innoviva, Inc. is 13.37 and the PB ratio is 1.37.